• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

皮肌炎作为卵巢癌的首发症状，接受新辅助化疗和间隔减瘤手术治疗。

Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.

作者信息

Christie Alan, McKay Neil, Nussey Fiona

机构信息

Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.

Rheumatic Diseases Unit, Western General Hospital, Edinburgh, UK.

出版信息

Gynecol Oncol Case Rep. 2013 Jul 16;6:13-5. doi: 10.1016/j.gynor.2013.07.002. eCollection 2013.

DOI:10.1016/j.gynor.2013.07.002
PMID:24371708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3862295/
Abstract

•Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids.•Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease.•Prognosis of ovarian cancer in context of dermatomyositis is poor.

摘要

•卵巢癌合并皮肌炎对新辅助卡铂和紫杉醇联合皮质类固醇治疗有反应。

•皮肌炎症状复发往往是疾病复发的首个迹象。

•皮肌炎背景下的卵巢癌预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7336/3862295/d694d14daba3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7336/3862295/d694d14daba3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7336/3862295/d694d14daba3/gr1.jpg

相似文献

1
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.皮肌炎作为卵巢癌的首发症状，接受新辅助化疗和间隔减瘤手术治疗。
Gynecol Oncol Case Rep. 2013 Jul 16;6:13-5. doi: 10.1016/j.gynor.2013.07.002. eCollection 2013.
2
[Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].[新辅助化疗联合间隔减瘤手术在晚期卵巢癌治疗中的应用——一项回顾性研究]
Klin Onkol. 2009;22(6):273-7.
3
Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer.在晚期卵巢癌患者中，减瘤手术和辅助化疗之间的时间间隔与总生存期相关。
Gynecol Oncol. 2018 Sep;150(3):446-450. doi: 10.1016/j.ygyno.2018.07.004. Epub 2018 Jul 9.
4
Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.原发性减瘤手术与新辅助化疗治疗Ⅲ/Ⅳ期卵巢癌：巴基斯坦女性围手术期发病率及生存数据比较
J Pak Med Assoc. 2015 Mar;65(3):306-9.
5
Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients.晚期子宫内膜癌的新辅助化疗：部分患者的一线希望
Arch Gynecol Obstet. 2016 Jan;293(1):47-53. doi: 10.1007/s00404-015-3841-8. Epub 2015 Aug 20.
6
Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.年龄校正的Charlson共病指数对晚期上皮性卵巢癌新辅助化疗后行肿瘤细胞减灭术患者围手术期并发症、辅助化疗使用情况及生存的预测价值。
J Obstet Gynaecol. 2017 Nov;37(8):1070-1075. doi: 10.1080/01443615.2017.1324413. Epub 2017 Jul 25.
7
Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.雌激素受体 1 mRNA 是新辅助化疗治疗的卵巢癌患者的预后因素：在新鲜组织活检中通过阵列和动力学 PCR 确定。
Endocr Relat Cancer. 2009 Dec;16(4):1241-9. doi: 10.1677/ERC-08-0342. Epub 2009 Sep 11.
8
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
9
Interval debulking surgery: an alternative for primary surgical debulking?间隔期肿瘤细胞减灭术：原发性肿瘤细胞减灭术的一种替代方案？
Semin Surg Oncol. 2000 Jul-Aug;19(1):49-53. doi: 10.1002/1098-2388(200007/08)19:1<49::aid-ssu8>3.0.co;2-z.
10
Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.组织病理学预测接受新辅助化疗和肿瘤细胞减灭术治疗的晚期上皮性卵巢癌患者的临床结局。
Gynecol Oncol. 2013 Dec;131(3):531-4. doi: 10.1016/j.ygyno.2013.09.030. Epub 2013 Oct 4.

引用本文的文献

1
Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review.皮肌炎和/或多发性肌炎作为卵巢癌的副肿瘤表现：一项系统综述
Contemp Oncol (Pozn). 2020;24(4):252-257. doi: 10.5114/wo.2020.102814. Epub 2021 Jan 4.
2
Rapid development and use of patient-specific ctDNA biomarkers to avoid a "rash decision" in an ovarian cancer patient.快速开发和使用针对特定患者的ctDNA生物标志物，以避免在卵巢癌患者中做出“轻率决定”。
Cold Spring Harb Mol Case Stud. 2019 Dec 13;5(6). doi: 10.1101/mcs.a004648. Print 2019 Dec.
3
Dermatomyositis - key to diagnosing ovarian cancer, monitoring treatment and detecting recurrent disease: Case report.

本文引用的文献

1
Morbidity and mortality in adult polymyositis and dermatomyositis.成人多发性肌炎和皮肌炎的发病率和死亡率。
Curr Rheumatol Rep. 2012 Jun;14(3):275-85. doi: 10.1007/s11926-012-0249-3.
2
Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.青少年和成人皮肌炎的临床特征、发病机制和治疗。
Nat Rev Rheumatol. 2011 Sep 27;7(11):664-75. doi: 10.1038/nrrheum.2011.139.
3
Dermatomyositis: a clinicopathological study of 40 patients.皮肌炎：40例患者的临床病理研究
皮肌炎——诊断卵巢癌、监测治疗及检测疾病复发的关键：病例报告
Gynecol Oncol Rep. 2017 Nov 28;23:1-3. doi: 10.1016/j.gore.2017.11.009. eCollection 2018 Feb.
4
Successful resection of liver metastasis detected by exacerbation of skin symptom in a patient with dermatomyositis accompanied by rectal cancer: a case report and literature review.皮肌炎伴直肠癌患者因皮肤症状加重检出肝转移灶并成功切除：1例报告及文献复习
Surg Case Rep. 2017 Dec;3(1):3. doi: 10.1186/s40792-016-0281-z. Epub 2017 Jan 4.
5
Paraneoplastic polymyositis presenting as a clinically occult breast cancer.副肿瘤性多肌炎表现为隐匿性乳腺癌。
Ann R Coll Surg Engl. 2017 Feb;99(2):e40-e43. doi: 10.1308/rcsann.2016.0301. Epub 2016 Sep 23.
6
Dermatomyositis as a paraneoplastic phenomenon in ovarian cancer.皮肌炎作为卵巢癌的副肿瘤现象。
BMJ Case Rep. 2016 Jul 8;2016:bcr2016215463. doi: 10.1136/bcr-2016-215463.
7
A rare case of severe myositis as paraneoplastic syndrome on breast cancer.一例罕见的以严重肌炎为副肿瘤综合征的乳腺癌病例。
World J Surg Oncol. 2015 Apr 1;13:134. doi: 10.1186/s12957-015-0534-5.
Am J Dermatopathol. 2009 Feb;31(1):61-7. doi: 10.1097/DAD.0b013e31818520e1.
4
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.皮肌炎和多发性肌炎中特定癌症类型的发病率：一项基于人群的研究。
Lancet. 2001 Jan 13;357(9250):96-100. doi: 10.1016/S0140-6736(00)03540-6.
5
Dermatomyositis.皮肌炎
Lancet. 2000 Jan 1;355(9197):53-7. doi: 10.1016/S0140-6736(99)05157-0.
6
Ovarian malignancy in patients with dermatomyositis and polymyositis: a retrospective analysis of fourteen cases.
J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):730-3. doi: 10.1016/s0190-9622(97)70109-9.
7
Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.皮肌炎与卵巢癌：7例报告及文献综述
J Rheumatol. 1993 Nov;20(11):1897-9.
8
Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.皮肌炎或多发性肌炎患者的癌症风险。一项基于人群的研究。
N Engl J Med. 1992 Feb 6;326(6):363-7. doi: 10.1056/NEJM199202063260602.